Latest EXPAREL Stories

2011-03-31 05:30:00

PARSIPPANY, N.J., March 31, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc.

2011-03-02 05:30:00

SAN DIEGO and PARSIPPANY, N.J., March 2, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that positive results from its Phase 1 study evaluating EXPAREL(TM) (bupivacaine extended-release liposome injection) in patients with moderate hepatic impairment, will be presented at the 2011 American Society for Clinical Pharmacology and Therapeutics (ASCPT) 112th Annual Meeting in Dallas, TX.